Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.832,09
-0,26%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Baudax Bio Inc (BXRX) Baudax Bio Inc (BXRX) Notizie

Baudax Bio Inc

BXRX
0,1864
0,00 (0,00%)
03 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
15/11/202323:25EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
15/11/202322:07EDGAR2Form 8-K - Current report
25/10/202313:57EDGAR2Form 8-K - Current report
13/10/202313:00EDGAR2Form 8-K - Current report
11/10/202322:47EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/10/202313:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/10/202314:00EDGAR2Form 8-K - Current report
29/9/202313:01EDGAR2Form 8-K - Current report
26/9/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
21/9/202323:30EDGAR2Form S-1/A - General form for registration of securities..
21/9/202322:48EDGAR2Form S-3/A - Registration statement under Securities Act of..
07/9/202323:16EDGAR2Form DEF 14A - Other definitive proxy statements
07/9/202322:10EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/9/202322:06EDGAR2Form 8-K/A - Current report: [Amend]
05/9/202323:24EDGAR2Form S-1 - General form for registration of securities under..
05/9/202322:13EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
05/9/202322:06EDGAR2Form 8-K - Current report
25/8/202322:01EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
25/8/202314:03EDGAR2Form 8-K - Current report
24/8/202323:07EDGAR2Form 8-K - Current report
24/8/202323:05EDGAR2Form 8-A12G - Registration of securities [Section 12(g)]
21/8/202314:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
21/8/202314:00EDGAR2Form 8-K - Current report
18/8/202322:40EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/8/202314:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
16/8/202314:11EDGAR2Form 8-K - Current report
15/8/202313:30EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
09/8/202323:28EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
09/8/202323:27EDGAR2Form 8-K/A - Current report: [Amend]
31/7/202322:55EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
31/7/202322:54EDGAR2Form 8-K/A - Current report: [Amend]
31/7/202322:48EDGAR2Form PRE 14A - Other preliminary proxy statements
25/7/202314:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
25/7/202314:01EDGAR2Form 8-K - Current report
17/7/202313:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
17/7/202313:00EDGAR2Form 8-K - Current report
05/7/202323:28EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
05/7/202323:26EDGAR2Form 8-K - Current report
28/6/202323:19EDGAR2Form S-3 - Registration statement under Securities Act of..
28/6/202322:31EDGAR2Form 8-K - Current report
Apertura: Min: Max:
Chiusura: 0,1864

La tua Cronologia

NASDAQ
BXRX
Baudax Bio
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network